MedPath

Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease

Not Applicable
Completed
Conditions
NAFLD
Interventions
Behavioral: General Advice
Behavioral: Low Glycemic Index Mediterranean Diet
Registration Number
NCT01798719
Lead Sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Brief Summary

Non-alcoholic fatty liver disease (NAFLD) is a clinical/biochemical condition associated with the metabolic syndrome. As the disease stems from excess calorie intake and lack of physical activity, the correction of unhealthy lifestyles is the background of any prevention and treatment strategy

Detailed Description

The majority of NAFLD patients are characterized by high body mass index, insulin resistance and they show a remarkably higher energy intake in comparison to individuals without hepatic steatosis. Several authors have proposed dietary weight loss strategies to ameliorate or reverse fatty liver because of the potential role of weight loss on the supposed risk factors of liver injury, mainly insulin resistance, free fatty acid levels, and pro-inflammatory and profibrotic adipokines. There are no definite data regarding how much and how rapidly weight loss should be to have the more favorable effects, but in obese children, the larger the weight loss, the larger the decrease of liver enzyme levels and the lower the prevalence of NAFLD. The American Gastroenterological Association recommends a weight loss target of 10% of baseline. A loss of at least 10% of body weight in obese patients is associated with a normalization of previously abnormal liver function tests as well as decreased hepatomegaly, but even a moderate weight loss (approximately 6% of baseline weight) can improve insulin resistance and intrahepatic liver content.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Subject enrolled in the cohort Nutriep assembled in 2005-2007
  • Moderate or severe NAFLD
Exclusion Criteria
  • Middle NAFLD
  • Not enrolled in the Nutriep cohort
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diet: Dietary AdviceGeneral AdviceSome general dietary advice about healthy dietary components, servings size and frequency of servings
Low glycemic index Mediterranean DietLow Glycemic Index Mediterranean DietLow glycemic index Mediterranean Diet prescription with indication about type of foods than can be consumed frequently (green foods), sometimes (yellow foods) and never (red foods)
Primary Outcome Measures
NameTimeMethod
Non-alcoholic Fatty Liver Disease Ultrasonography ScoreSix months

A semiquantitative score to measure Non-alcoholic Fatty Liver Disease will be used

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laboratory of Epidemiology and Biostatistics, IRCCS Saverio de Bellis

🇮🇹

Castellana Grotte, BA, Italy

Laboratory of Epidemiology and Biostatistics, IRCCS Saverio de Bellis
🇮🇹Castellana Grotte, BA, Italy
© Copyright 2025. All Rights Reserved by MedPath